Flo Health, a leading women’s health app, has raised more than $200 million in a Series C investment from General Atlantic, a prominent global growth investor. This investment propels Flo’s valuation beyond $1 billion, making it the first purely digital consumer women’s health app to achieve unicorn status.
Flo Health’s mission is to support women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. With a team of over 120 doctors and health experts, Flo offers a comprehensive platform that includes cycle and ovulation tracking, the ability to monitor over 70 symptoms, tailored health insights, expert tips, and a private digital discussion community.
“Reaching unicorn status is a significant milestone for Flo and the entire femtech industry,” said Dmitry Gurski, co-founder and CEO of Flo Health. “When we started Flo, we identified a huge gap in women’s health services. Now, we’re a leader in a global movement to make women’s health a priority everywhere. We’re already helping hundreds of millions of women, and our goal is to reach 1 billion women through our global pro-social program.”
Flo’s partnership with General Atlantic will support its next phase of growth, focusing on expanding into new user segments, including perimenopause and menopause, enhancing its tech-driven health insights, and pursuing strategic expansion opportunities. To achieve these goals, Flo plans to increase its R&D headcount and invest in top-tier talent across its global offices in Europe and North America.
“We have been lucky enough to watch the Flo team over the past five years build a beloved, mission-critical app for women globally, and now we have the fortunate opportunity to partner with Dmitry and his team,” said Jessie Cai, Principal at General Atlantic. “We are excited about their big vision and the innovation ahead for the broader women’s health and wellness ecosystem.”
Anna Klepchukova, Chief Medical Officer of Flo Health, emphasized the importance of Flo’s mission: “With women spending 25% more of their lives in poor health compared to men, we’re committed to changing this unacceptable status quo. As the #1 OB-GYN-recommended cycle tracking app, Flo empowers users with tailored health insights, enabling better-informed conversations with healthcare providers.”
Flo Health has seen substantial growth, supporting nearly 70 million monthly active users and close to 5 million paid subscribers as of June 2024. Flo’s gross bookings for 2024 are expected to exceed $200 million, reflecting an approximately 50% year-over-year increase, according to the company. As part of the transaction, Tanzeen Syed, Managing Director and Head of Consumer Internet and Technology at General Atlantic, and Jessie Cai will join Flo’s Board of Directors.
